GlassScriptPhysician profile
Sunil G Chand
NPI 1205800257
$24,069.35
in general payments reported to CMS, 2019-2025
18 companies · $70.17 in 2025
The $70.17 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14K · 2020: $4,108 · 2021: $4,738 · 2022: $441 · 2023: $326 · 2024: $180 · 2025: $70.17.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $576.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $575.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $22,985.23 | 2019-2024 | Watchman Access System |
| Abbvie INC. | $337.78 | 2019-2023 | Vraylar |
| Gilead Sciences, INC. | $173.28 | 2019-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $120.40 | 2019-2025 | Xifaxan |
| Philips North America LLC | $60.33 | 2022-2025 | Vest Therapy Und |
| Lilly USA, LLC | $42.10 | 2023 | Mounjaro, Trulicity |
| Orexo US, INC. | $42.04 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $41.02 | 2019-2022 | |
| Allergan, INC. | $40.00 | 2019 | |
| Otsuka America Pharmaceutical, INC. | $36.60 | 2020-2023 | Rexulti |
| Tactile Systems Technology INC | $35.14 | 2025 | Flexitouch Plus, Nimbl |
| Supernus Pharmaceuticals, INC. | $29.22 | 2020 | |
| Novo Nordisk INC | $28.00 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $26.77 | 2019 | |
| Pfizer INC. | $19.93 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $18.10 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $17.24 | 2022 | |
| Dexcom, INC. | $16.17 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sunil Chand listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.